Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting
Clinical trial NCT04799990 · WITHDRAWN
Trial details
- NCT number
- NCT04799990
- Sponsor
- AbbVie
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-23
- Primary completion
- 2022-03-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.